Study guide

13.2 Ethics, Confidentiality & Generic Substitution

DHA Pharmacist Licensing Assessment PHO5481

Track your progress as you read

Finished sections get a check mark.

1 Exam Overview & Licensing Pathway

1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan

2 Cardiovascular Pharmacology

2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents

3 Endocrine & Metabolic Pharmacology

3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents

4 Anti-Infective Pharmacology

4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars

5 CNS, Psychiatric & Pain Pharmacology

5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine

6 Respiratory, GI & Hematology Pharmacology

6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents

7 Pharmaceutical Care: Cardiometabolic Disease

7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management

8 Pharmaceutical Care: Respiratory, Rheumatology & Infection

8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship

9 Counseling, Monitoring & Special Populations

9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making

10 Pharmaceutical Calculations I

10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation

11 Pharmaceutical Calculations II

11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents

12 UAE Pharmacy Law & Regulation

12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity

13 Controlled Drugs, Ethics & Pharmacovigilance

13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal

14 Pharmacokinetics I: ADME

14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination

15 Pharmacokinetics II: Kinetics, Dosing & TDM

15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring

16 OTC Medicines & Self-Care

16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin

17 Medication Safety

17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition

18 Sterile & Nonsterile Compounding

18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding

19 Pharmaceutics, Biopharmaceutics & Toxicology

19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes

20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics

20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics

13.2 Ethics, Confidentiality & Generic Substitution

Key Takeaways Explain This Topic AI

The four ethical pillars — autonomy, beneficence, non-maleficence and justice — map directly onto everyday dispensing decisions

Patient confidentiality may be breached only for serious-harm prevention or legal compulsion, and even then disclosure is limited to what is necessary

Direct-to-consumer advertising of prescription-only medicines is prohibited in the UAE, and industry gifts or incentives create declarable conflicts of interest

Generic substitution relies on bioequivalence; caution applies to narrow-therapeutic-index drugs such as levothyroxine, phenytoin, warfarin and ciclosporin

Therapeutic substitution (a different drug in the same class) is not generic substitution and requires prescriber agreement

Last updated: August 2026

The Four Pillars in Pharmacy Practice

Pharmacy ethics questions on the DHA exam are usually scenario-based applications of the four classical principles:

Autonomy — respecting the patient's right to informed choice. In practice: explaining options honestly, honouring a competent patient's refusal, and not concealing an error because disclosure is uncomfortable.

Beneficence — acting for the patient's benefit. In practice: proactively identifying interactions, counselling on adherence, referring red-flag symptoms rather than simply selling a product.

Non-maleficence — first, do no harm. In practice: refusing to dispense an unsafe or forged prescription even under pressure, checking allergy history, declining to supply antibiotics without a valid prescription.

Justice — fair treatment and fair allocation. In practice: not prioritising wealthier or pushier customers, applying substitution and pricing rules consistently, and equitable access during shortages.

Exam questions rarely ask for definitions alone; they present a dilemma — for example, a relative demanding information, or a profitable but inappropriate sale — and expect you to pick the option balancing autonomy and confidentiality against genuine harm risk.

Confidentiality and Health-Data Duties

A pharmacist holds health information in confidence as a legal and professional duty , not merely a courtesy. Prescription details, diagnoses inferred from medicines, and even the fact that someone is a patient are protected. Practical rules:

Family and employer inquiries. Do not disclose a patient's medicines or conditions to spouses, relatives, employers or insurers without the patient's explicit consent — however well-meaning the request. For children and patients lacking capacity, disclosure is to the legal guardian and limited to what care requires.

Exceptions. Confidentiality may be overridden only in narrow circumstances: to prevent serious harm to the patient or others, or under legal compulsion (a court order or a specific statutory duty to report). Even then, disclose the minimum necessary to the proper authority , and document the decision and its rationale.

Data handling. Health data must be stored securely, access-restricted, and never posted to social media or discussed in public areas. De-identified teaching use still demands genuine anonymisation.

Informed consent in pharmacy means the patient understands, in language they comprehend, what a medicine is for, how to take it and the material risks before agreeing — consent is a process of communication, not a signature.

Conflicts of Interest, Advertising and Professional Boundaries

Conflicts of interest arise when commercial gain could distort professional judgement — gifts, hospitality or incentive schemes from manufacturers that reward dispensing particular brands. The ethical rule is to avoid, declare and never allow inducements to influence clinical decisions ; substitution and recommendation decisions must rest on evidence, regulation and patient need.

Advertising. UAE rules prohibit direct-to-consumer advertising of prescription-only medicines (POM) ; promotion of POMs is confined to healthcare professionals through regulated channels, while over-the-counter products may be advertised within approved content rules. A pharmacist who promotes a POM brand to the public for a supplier's reward breaches both advertising and conflict-of-interest standards.

Conscientious objection has boundaries: a pharmacist with a genuine moral objection to supplying a lawful product should ensure the patient is referred promptly to another pharmacist or pharmacy so lawful care is not obstructed — objection protects the practitioner's conscience, it does not license obstruction or judgement of the patient.

Fitness to practise is a collective duty. A colleague practising while impaired — through substance misuse, untreated illness or conduct that endangers patients — should be supported toward help, but where patient safety is at risk there is a duty to report to the employer and, where necessary, the licensing authority. Protecting patients outranks protecting a colleague's reputation.

Generic Substitution

Generic substitution means dispensing a different manufacturer's product containing the same active ingredient, strength and dosage form in place of the prescribed brand. Its legal and scientific basis is bioequivalence : a registered generic must demonstrate that its rate and extent of absorption fall within the accepted equivalence limits of the reference product (conventionally, the 90% confidence interval for key pharmacokinetic measures lies within 80–125%). Because registered generics meet this standard, substitution is permitted — and often encouraged by payers — unless an exception applies:

The prescriber has explicitly marked no substitution or brand-necessary dispensing.

The medicine is a narrow-therapeutic-index (NTI) or critical-dose drug where small exposure shifts matter — classic examples are levothyroxine, phenytoin, warfarin and ciclosporin . Many authorities and guidelines advise keeping patients on a consistent product for these, and any enforced switch warrants monitoring.

No registered, bioequivalent generic exists for that product in the UAE market.

When a switch is made, the pharmacist should inform the patient , explain that appearance may differ while the active ingredient is unchanged, record the product dispensed, and counsel the patient to report any change in effect or new adverse effects — this documentation protects continuity if a problem later surfaces.

Generic vs therapeutic substitution

  • Generic substitution Therapeutic substitution
  • Active ingredient Same Different drug, same pharmacological class
  • Scientific basis Bioequivalence Comparable class effect

Typical authority Pharmacist may do under regulation, unless barred Requires prescriber agreement — not a pharmacist's unilateral decision

Example Brand atorvastatin → registered generic atorvastatin Atorvastatin → rosuvastatin

Confusing these two is a classic exam trap: swapping omeprazole for esomeprazole, or one ACE inhibitor for another, is therapeutic substitution and needs the prescriber's authorisation, however reasonable it seems clinically.